Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1744-1754

  Jorgensen, James H ^a   Crawford, Sharon A ^a   Fulcher, Letitia C ^a   Glennen, Anita ^b   Harrington, Susan M ^c   Swenson, Jana ^d   Lynfield, Ruth ^b   Murray, Patrick R ^c   Tenover, Fred C ^d  

^a University of Texas Health Science Center at San Antonio   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CARBON DIOXIDE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; MECILLINAM; MEROPENEM; MINOCYCLINE; NALIDIXIC ACID; PENICILLIN BINDING PROTEIN; PENICILLIN G; RIFAMPICIN;

AGAR GEL DIFFUSION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL MUTATION; BACTERIUM ISOLATE; BIOSAFETY; CLINICAL LABORATORY; CULTURE MEDIUM; DILUTION; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; LABORATORIES; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EQUUS CABALLUS; NEISSERIA MENINGITIDIS; OVIS ARIES;

EID: 33646562482     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1744-1754.2006     Document Type: Article

References (28)

1. Antignac, A., M. Ducos-Galand, A. Guiyoule, R. Pires, J.-M. Alonso, and M.-K. Taha. 2003. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin. Infect. Dis. 37:912-920.
2. Antignac, A., P. Kriz, G. Tzanakaki, J.-M. Alonso, and M.-K. Taha. 2001. Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J. Antimicrob. Chemother. 47:285-296.
3. Block, C., Y. Davidson, and N. Keller. 1998. Unreliability of disc diffusion test for screening for reduced penicillin susceptibility in Neisseria meningitidis. J. Clin. Microbiol. 36:3103-3104.
4. Brunden, M. N., G. E. Zurenko, and B. Kapik. 1992. Modification of the error-bounded classification scheme for use with two MIC breakpoints. Diagn. Microbiol. Infect. Dis. 15:135-140.
5. Campos, J., G. Trujillo, T. Seuba, and A. Rodgriguez. 1992. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampiciliin. Antimicrob. Agents Chemother. 36:1028-1031.
6. Campos, J., P. M. Mendelman, M. U. Sako, D. O. Chaffin, A. L. Smith, and J. A. Sáenz-Nieto. 1987. Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob. Agents Chemother. 31:1478-1482.
7. Centers for Disease Control and Prevention. 2002. Laboratory-acquired meningococcal disease-United States, 2000. Morb. Mortal. Wkly. Rep. 51:141-144.
8. Clinical and Laboratory Standards Institute/NCCLS. 2001. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M23-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Clinical and Laboratory Standards Institute/NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Clinical and Laboratory Standards Institute/NCCLS. 2003. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, PA.
11. Clinical and Laboratory Standards Institute/NCCLS. 2005. Performance standards for antimicrobial susceptibility testing. Supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa.
12. Clinical and Laboratory Standards Institute/NCCLS. 2006. Performance standards for antimicrobial susceptibility testing. Supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
13. Crawford, S. A., K. R. Fiebelkorn, J. E. Patterson, and J. H. Jorgensen. 2005. International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to tei(B). Antimicrob. Agents Chemother. 49:1198-1200.
14. Dahar, O., H. A. Lopardo, and E. A. Rubeglio. 2002. Value of Etest penicillin V and penicillin G strips for penicillin susceptibility testing of Neisseria meningitidis. Diagn. Microbiol. Infect. Dis. 43:119-121.
15. Fiebelkorn, K. R., S. A. Crawford, and J. H. Jorgensen. 2005. Mutations in folP associated with elevated sulfonamide MICs in Neisseria meningitidis clinical isolates from five continents. Antimicrob. Agents Chemother. 49:536-540.
16. Fraser, A., A. Gafter-Gvili, and P. Leibovici. 2005. Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomized trials. Eur. J. Clin. Microbiol. Infect. Dis. 24:172-181.
17. Jackson, L. A., F. C. Tenover, C. Baker, B. D. Plikaytis, M. W. Reeves, S. A. Stocker, R. E. Weaver, and J. D. Wenger. 1994. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. J. Infect. Dis. 169:438-441.
18. Jorgensen, J. H., S. A. Crawford, and K. R. Fiebelkorn. 2005. Susceptibility of Neisseria meningitidis to sixteen antimicrobial agents and characterization of resistance mechanisms affecting some agents. J. Clin. Microbiol. 43:3162-3171.
19. Nicolas, P., J. D. Cavallo, R. Fabre, and G. Martet. 1998. Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin. Bull. W.H.O. 76:393-400.
20. Pascual, A., P. Joyanes, L. Martínez-Martínez, I. Suárez, and E. J. Perea. 1996. Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis. J. Clin. Microbiol. 34:588-591.
21. Rainbow, J., E. Cebelinski, J. Bartkus, A. Glennen, D. Boxrud, and R. Lynfield. 2005. Rifampin-resistant meningococcal disease. Emerg. Infect. Dis. 11:977-979.
22. Richter, S. S., K. A. Gordon, P. R. Rhomberg, M. A. Pfaller, and R. N. Jones. 2001. Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99. Diagn. Microbiol. Infect. Dis. 41:83-88.
23. Rosenstein, N. E., S. A. Stocker, T. Popovic, F. C. Tenover, and B. A. Perkins. 2000. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin. Infect. Dis. 30:212-213.
24. Saez-Nieto, J. A., R. Lujan, S. Berron, J. Campos, M. Vinas, C. Fuste, J. A. Vazquez, Q.-Y. Zhang, L. D. Bowler, J. V. Martinez-Suarez, and B. G. Spratt. 1992. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin. Infect. Dis. 14:394-402.
25. Schultz, T. R., P. A. White, and J. W. Tapsall. 2005. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob. Agents Chemother. 49:1753-1760.
26. Spratt, B. G. 1977. The mechanism of action of mecillinam. J. Antimicrob. Chemother. 3(Suppl. B):13-19.
27. Stefanelli, P., C. Fazio, A. Neri, T. Sofia, and P. Mastrantonio. 2004. Emergence in Italy of a Neisseria meningitidis clone with decreased susceptibility to penicillin. Antimicrob. Agents Chemother. 48:3103-3106.
28. Vazquez, J. A., L. Arreaza, C. Block, I. Ehrland, S. J. Gray, S. Heuberger, S. Hoffmann, P. Kriz, P. Nicolas, P. Olcen, A. Skoczynska, L. Spanjaard, P. Stefanelli, M.-K. Taha, and G. Tzanakaki. 2003. Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob. Agents Chemother. 47:3430-3434.